HIV-associated lipodystrophy - definição. O que é HIV-associated lipodystrophy. Significado, conceito
Diclib.com
Dicionário ChatGPT
Digite uma palavra ou frase em qualquer idioma 👆
Idioma:

Tradução e análise de palavras por inteligência artificial ChatGPT

Nesta página você pode obter uma análise detalhada de uma palavra ou frase, produzida usando a melhor tecnologia de inteligência artificial até o momento:

  • como a palavra é usada
  • frequência de uso
  • é usado com mais frequência na fala oral ou escrita
  • opções de tradução de palavras
  • exemplos de uso (várias frases com tradução)
  • etimologia

O que (quem) é HIV-associated lipodystrophy - definição


HIV-associated lipodystrophy         
HUMAN DISEASE
Hiv-associated lipodystrophy syndrome; HIV/HAART-associated lipodystrophy; HAART-associated lipodystrophy; Lipodystrophy in HIV-infected patients; LD-HIV
HIV-associated lipodystrophy is a condition characterized by loss of subcutaneous fat associated with infection with HIV.
HIV-associated nephropathy         
HUMAN DISEASE
Hivan; HIV nephropathy; HIV-Accociated Nephropathy; Aids-associated nephropathy; HIV-Associated Nephropathy; HIV associated nephropathy
HIV-associated nephropathy (HIVAN) refers to kidney disease developing in association with infection by human immunodeficiency virus, the virus that causes AIDS. The most common, or "classical", type of HIV-associated nephropathy is a collapsing focal segmental glomerulosclerosis (FSGS), though other forms of kidney disease may also occur.
Marfanoid–progeroid–lipodystrophy syndrome         
HUMAN DISEASE
Marfan lipodystrophy syndrome; Marfan-progeroid-lipodystrophy syndrome; Progeroid fibrillinopathy; Marfanoid-progeroid-lipodystrophy syndrome; Marfanoid-progeroid-lipodystrophy; Marfanoid–progeroid–lipodystrophy; Marfan–progeroid–lipodystrophy; Marfan–progeroid–lipodystrophy syndrome; Marfan-progeroid-lipodystrophy; Marfan-progeroid lipodystrophy; Marfanoid-progeroid lipodystrophy; Marfanoid–progeroid lipodystrophy; Marfan–progeroid lipodystrophy; MFLS; Marfanoid lipodystrophy syndrome; Marfanoid lipodystrophy; Marfan lipodystrophy
Marfanoid–progeroid–lipodystrophy syndrome (MPL), also known as Marfan lipodystrophy syndrome (MFLS) or progeroid fibrillinopathy, is an extremely rare medical condition which manifests as a variety of symptoms including those usually associated with Marfan syndrome, an appearance resembling that seen in neonatal progeroid syndrome (NPS; also known as Wiedemann–Rautenstrauch syndrome), and severe partial lipodystrophy. It is a genetic condition that is caused by mutations in the FBN1 gene, which encodes profibrillin, and affects the cleavage products of profibrillin, fibrillin-1, a fibrous structural protein, and asprosin, a glucogenic protein hormone.